BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Radenkovic S, Witters P, Morava E. Central nervous involvement is common in PGM1-CDG. Mol Genet Metab 2018;125:200-4. [PMID: 30262252 DOI: 10.1016/j.ymgme.2018.08.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Backe PH, Laerdahl JK, Kittelsen LS, Dalhus B, Mørkrid L, Bjørås M. Structural basis for substrate and product recognition in human phosphoglucomutase-1 (PGM1) isoform 2, a member of the α-D-phosphohexomutase superfamily. Sci Rep 2020;10:5656. [PMID: 32221390 DOI: 10.1038/s41598-020-62548-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Park JH, Marquardt T. Treatment Options in Congenital Disorders of Glycosylation. Front Genet 2021;12:735348. [PMID: 34567084 DOI: 10.3389/fgene.2021.735348] [Reference Citation Analysis]
3 Verheijen J, Tahata S, Kozicz T, Witters P, Morava E. Therapeutic approaches in Congenital Disorders of Glycosylation (CDG) involving N-linked glycosylation: an update. Genet Med. 2020;22:268-279. [PMID: 31534212 DOI: 10.1038/s41436-019-0647-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
4 Donoghue SE, White SM, Tan TY, Kowalski R, Morava E, Yaplito-Lee J. Galactose treatment of a PGM1 patient presenting with restrictive cardiomyopathy. JIMD Rep 2021;57:29-37. [PMID: 33473337 DOI: 10.1002/jmd2.12177] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Conte F, Morava E, Bakar NA, Wortmann SB, Poerink AJ, Grunewald S, Crushell E, Al-Gazali L, de Vries MC, Mørkrid L, Hertecant J, Brocke Holmefjord KS, Kronn D, Feigenbaum A, Fingerhut R, Wong SY, van Scherpenzeel M, Voermans NC, Lefeber DJ. Phosphoglucomutase-1 deficiency: Early presentation, metabolic management and detection in neonatal blood spots. Mol Genet Metab 2020;131:135-46. [PMID: 33342467 DOI: 10.1016/j.ymgme.2020.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang X, Wang J, Shi X, Pan C, Liu H, Dong Y, Dong R, Mang J, Xu Z. Proteomic analyses identify a potential mechanism by which extracellular vesicles aggravate ischemic stroke. Life Sciences 2019;231:116527. [DOI: 10.1016/j.lfs.2019.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Conte F, van Buuringen N, Voermans NC, Lefeber DJ. Galactose in human metabolism, glycosylation and congenital metabolic diseases: Time for a closer look. Biochim Biophys Acta Gen Subj 2021;1865:129898. [PMID: 33878388 DOI: 10.1016/j.bbagen.2021.129898] [Reference Citation Analysis]
8 Beamer LJ. Enzyme dysfunction at atomic resolution: Disease-associated variants of human phosphoglucomutase-1. Biochimie 2021;183:44-8. [PMID: 32898648 DOI: 10.1016/j.biochi.2020.08.017] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]